Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Open-market buy Director bought 225 shares at $4.50 ($1,013)
  2. 4 Open-market buy Director bought 200 shares at $4.50 ($900)
  3. 4 Open-market buy Director bought 3,000 shares at an average $4.55 ($13,636)
  4. 4 Open-market buy Director bought 250 shares at $4.35 ($1,088)
  5. 4 Open-market buy Director bought 5,901 shares at an average $4.57 ($26,945)
  6. 4/A Open-market buy Director bought 750 shares at $4.10 ($3,075)
  7. 4 Open-market buy Director bought 750 shares at $4.10 ($3,075)
  8. 4 Open-market buy Director bought 700 shares at $4.30 ($3,010)
  9. 4 Open-market buy Director bought 4,000 shares at an average $3.59 ($14,350)
  10. 4 Open-market buy Director bought 1,500 shares at $3.91 ($5,865)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Option exercise President and CEO acquired 1,000 shares (option exercise)
  13. 4 Option exercise Vice President and CSO acquired 1,000 shares (option exercise)
  14. 4 Other acquisition Director acquired 39,355 shares (code W)
  15. 4 Open-market buy Director bought 1,500 shares at an average $3.98 ($5,965)
  16. 4 Open-market buy Director bought 4,000 shares at an average $3.68 ($14,734)
  17. 4 Open-market buy Vice President and CSO bought 1,000 shares at $3.20 ($3,200)
  18. 4 Option exercise President and CEO acquired 1,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 13 · 256 filings